Home » Topics » BioWorld

BioWorld
RSS

SYNERGEN LEADS BIOTECH STOCK SLIDE

Sep. 24, 1991

GENPHARM GETS RIGHTS TO TRANSGENIC MICE

Sep. 24, 1991

SALE OF CETUS' PCR PASSES HURDLE

Sep. 24, 1991

SHAMAN GETS APPROVAL TO TEST ANTI-VIRAL

Sep. 24, 1991

MONTGOMERY SECURITIES CONFERENCE

Sep. 24, 1991

MICROPROBE GRANT FOR ANTIGENE TECHNOLOGY

Sep. 23, 1991

APPOINTMENTS AND ADVANCEMENTS

Sep. 23, 1991

BTGC GROWTH HORMONE APPROVED

Sep. 23, 1991

PREMIUM FOR GI IS NO BLOCKBUSTER

Sep. 23, 1991

AIDS ADJUNCT GETS ORPHAN DESIGNATION

Sep. 20, 1991

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...